NCT01014507View on ClinicalTrials.gov

Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Hodgkins Lymphoma
Interventions
DRUG

8 cycles BEACOPPesc plus oral contraceptive

DRUG

8 cycles BEACOPPesc plus Goserelin

All Listed Sponsors
lead

University of Cologne

OTHER

NCT01014507 - Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma | Biotech Hunter | Biotech Hunter